Articles dans des revues avec comité de lecture (179)
  1. 143. Vos, B., Moreno, C., Nagy, N., Adler, M., Fery, F., Cnop, M., Vereerstraeten, P., & Devière, J. (2011). Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. Acta Gastro-Enterologica Belgica (English ed.), 74(3), 389-394.
  2. 144. Deltenre, P., Moreno, C., Tran, A., Ollivier, I., Provôt, F., Stanke, F., Lazrek, M., Castel, H., Canva, V., Louvet, A., Colin, M., Glowacki, F., Dharancy, S., Henrion, J., Hazzan, M., Noel, C., & Mathurin, P. (2011). Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy. Alimentary pharmacology & therapeutics, 34(4), 454-461. doi:10.1111/j.1365-2036.2011.04741.x
  3. 145. Cheung, K.-J., Tilleman, K., Deforce, D., Colle, I., Moreno, C., Gustot, T., & Van Vlierberghe, H. (2011). Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C. European journal of gastroenterology & hepatology, 23(8), 701-710. doi:10.1097/MEG.0b013e3283471b74
  4. 146. Trepo, E., Potthoff, A., Pradat, P., Bakshi, R., Young, B., Lagier, R., Moreno, C., Verset, L., Cross, R., Degré, D., Lemmers, A., Gustot, T., Berthillon, P., Rosenberg, W., Trepo, C., Sninsky, J., Adler, M., & Wedemeyer, H. (2011). Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease. Journal of hepatology, 55(1), 38-44. doi:10.1016/j.jhep.2010.10.018
  5. 147. Trepo, E., Pradat, P., Potthoff, A., Momozawa, Y., Quertinmont, E., Gustot, T., Lemmers, A., Berthillon, P., Amininejad, L., Chevallier, M., Schlué, J., Kreipe, H., Devière, J., Manns, M., Trepo, C., Sninsky, J., Wedemeyer, H., Franchimont, D., & Moreno, C. (2011). Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology, 54(1), 60-69. doi:10.1002/hep.24350
  6. 148. Orlent, H., Reynaert, H., Bourgeois, S., Dideberg, V., Adler, M., Colle, I., De Maeght, S., Laleman, W., Michielsen, P., Moreno, C., Mulkay, J.-P., Starkel, P., Delwaide, J., & Belgian Association for the Study of the Liver, (2011). IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use? Acta gastro-enterologica Belgica (Ed. multilingue), 74(2), 317-322.
  7. 149. Zeuzem, S., Andreone, P., Pol, S., Lawitz, E., Diago, M., Roberts, S., Focaccia, R., Younossi, Z., Foster, G. R., Horban, A., Ferenci, P., Nevens, F., Müllhaupt, B., Pockros, P., Terg, R., Shouval, D., van Hoek, B., Weiland, O., Van Heeswijk, R., De Meyer, S., Luo, D., Boogaerts, G., Polo, R., Picchio, G., Beumont, M., & Moreno, C. (2011). Telaprevir for retreatment of HCV infection. The New England journal of medicine, 364(25), 2417-2428. doi:10.1056/NEJMoa1013086
  8. 150. Trepo, E., Franchimont, D., & Moreno, C. (2011). Association of PNPLA3 (rs738409 C>G) with liver damage in liver diseases: One step closer to personalized medicine? Personalized medicine, 8, 595-597.
  9. 151. Manns, M., Reesink, H., Berg, T., Dusheiko, G., Flisiak, R., Marcellin, P., Moreno, C., Lenz, O., Meyvisch, P., Peeters, M. P., Sekar, V., Simmen, K., & Verloes, R. (2011). Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial. Antiviral therapy, 16(7), 1021-1033. doi:10.3851/IMP1894
  10. 152. Moreno, C., Langlet, P., Hittelet, A.-B., Lasser, L., Degré, D., Evrard, S., Colle, I., Lemmers, A., Devière, J., & Le Moine, O. (2010). Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. Journal of hepatology, 53(6), 1117-1122. doi:10.1016/j.jhep.2010.05.030
  11. 153. Brenard, R., Chapaux, X., Mengeot, P., Deltenre, P., Henrion, J., De Maeght, S., Horsmans, Y., Borbath, I., Lerut, J., Sempoux, C., Leenaerts, A., Van Cauter, J., Francque, S., Serste, T., Moreno, C., & Orlent, H. (2010). Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: The Belgian Registry based on 30 patients. European journal of gastroenterology & hepatology, 22(10), 1253-1259. doi:10.1097/MEG.0b013e32833ac4a1
  12. 154. Dharancy, S., Body-Malapel, M., Louvet, A., Berrebi, D., Gantier, E., Gosset, P., Viala, J., Hollebecque, A., Moreno, C., Philpott, D. D., Girardin, S. S., Sansonetti, P., Desreumaux, P., Mathurin, P., & Dubuquoy, L. (2010). Neutrophil Migration During Liver Injury Is Under Nucleotide-Binding Oligomerization Domain 1 Control. Gastroenterology, 138(4), 1546-1556.e5. doi:10.1053/j.gastro.2009.12.008
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Suivant >>